A Randomized Crossover Trial of the Functional Performance, Safety and Acceptability of the Wonderleaf Condom
Following a pilot function study in 2017, this main function study is a two-period, cross-over randomized trial to determine the functional performance, safety and acceptability of the Wondaleaf female condom in comparison to the FC2 female condom.
The study is enrolling 220 women couples who will use five condoms of each (control and test). Fieldwork commenced in April 2019.
|Funder/Sponsor:||Twin Catalyst, Malaysia|
|Principal Investigators:||Dr M Beksinska (MRU)
Dr Ivana Beesham (MRU)
|Sites:||Commercial City Site|